A shared """"""""Cell Purification and Analysis Laboratory"""""""" is proposed as this Core for the program project? The primary responsibilities of the Core are two fold. First, this core is charged with the responsibility of? processing human and murine hematopoietic tissues in order to isolate and purify phenotypically defined? populations of hematopoietic cells using immunomagnetic selection, enrichment, or depletion procedures? and flow cytometric cell sorting. Second, the core will coordinate, perform, analyze, and assist in interpreting? the results of flow cytometric analyses of hematopoietic and non-hematopoietic unmariipulated or? transduced cells used for or resulting from the proposed studies. In performing these essential duties, this Core will serve a fundamental function for the conduct of all subprojects of the program project. During the? previous funding period, this core provided valuable assistance for the performance of all projects of the? program as is evident by the list of publications benefiting directly from services provided by this Core.? Tie flow cytometry resource facility (FCRF), which will house the proposed core, is fully equipped with? state of the art instrumentation for the performance of sophisticated flow cytometry procedures required by? the proposed studies and is a core unit of the Indiana University Cancer Center. The FCRF is currently? located on the first floor of the Indiana Cancer Research Institute in a separate 850 sq. ft. laboratory with an? adjoining office/computer room (170 square feet). This central location of the FCRF? greatly facilitates the accessibility of this core to the laboratories of all the principal investigators of the? program project.? The shared cell purification and analysis laboratory will provide for participants in the program project an? economical use of equipment and space as well as necessary cell populations required for the conduct of? their research. In addition, such a core laboratory will be positioned to share and disseminate scientific? information collected from the different projects of this program.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL053586-14
Application #
7642433
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
14
Fiscal Year
2008
Total Cost
$157,211
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Stein, Stefan; Scholz, Simone; Schwäble, Joachim et al. (2013) From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease. Hum Gene Ther Clin Dev 24:86-98
Song, Liujiang; Kauss, M Ariel; Kopin, Etana et al. (2013) Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo. Cytotherapy 15:986-98
Liu, Ying; Ballman, Kimberly; Li, Deqiang et al. (2012) Impaired function of Fanconi anemia type C-deficient macrophages. J Leukoc Biol 91:333-40
Hawkins, Troy B; Dantzer, Jessica; Peters, Brandon et al. (2011) Identifying viral integration sites using SeqMap 2.0. Bioinformatics 27:720-2
Ou, Xuan; Chae, Hee-Don; Wang, Rui-Hong et al. (2011) SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse. Blood 117:440-50
Grez, Manuel; Reichenbach, Janine; Schwäble, Joachim et al. (2011) Gene therapy of chronic granulomatous disease: the engraftment dilemma. Mol Ther 19:28-35
Rohrabaugh, Sara L; Campbell, Timothy B; Hangoc, Giao et al. (2011) Ex vivo rapamycin treatment of human cord blood CD34+ cells enhances their engraftment of NSG mice. Blood Cells Mol Dis 46:318-20
Broxmeyer, Hal E; Lee, Man-Ryul; Hangoc, Giao et al. (2011) Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood 117:4773-7
Rohrabaugh, Sara L; Hangoc, Giao; Kelley, Mark R et al. (2011) Mad2 haploinsufficiency protects hematopoietic progenitor cells subjected to cell-cycle stress in vivo and to inhibition of redox function of Ape1/Ref-1 in vitro. Exp Hematol 39:415-23
Liu, Ying; Timani, Khalid; Mantel, Charlie et al. (2011) TIP110/p110nrb/SART3/p110 regulation of hematopoiesis through CMYC. Blood 117:5643-51

Showing the most recent 10 out of 158 publications